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A B S T R A C T
Background: Since the Coronavirus disease-19(COVID-19) pandemic, the healthcare systems are reallocating
their medical resources, with consequent narrowed access to elective surgery for benign conditions such as
gallstone disease(GD). This survey represents an overview of the current policies regarding the surgical man-
agement of patients with GD during the COVID-19 pandemic.
Methods: A Web-based survey was conducted among 36 Hepato-Prancreato-Biliary surgeons from 14 Countries.
Through a 17-item questionnaire, participants were asked about the local management of patients with GD since
the start of the COVID-19 pandemic.
Results: The majority (n= 26,72.2%) of surgeons reported an alarming decrease in the cholecystectomy rate for
GD since the start of the pandemic, regardless of the Country: 19(52.7%) didn't operate any GD, 7(19.4%)
reduced their surgical activity by 50–75%, 10(27.8%) by 25–50%, 1(2.8%) maintained regular activity.
Currently, only patients with GD complications are operated. Thirty-two (88.9%) participants expect these
changes to last for at least 3 months.
In 15(41.6%) Centers, patients are currently being screened for SARS-CoV-2 infection before cholecystectomy
[in 10(27.8%) Centers only in the presence of suspected infection, in 5(13.9%) routinely]. The majority of
surgeons (n= 29,80.6%) have adopted a laparoscopic approach as standard surgery, 5(13.9%) perform open
cholecystectomy in patients with known/suspected SARS-CoV-2 infection, and 2(5.6%) in all patients.
Conclusion: In the ongoing COVID-19 emergency, the surgical treatment of GD is postponed, resulting in a huge
number of untreated patients who could develop severe morbidity. Updated guidelines and dedicated pathways
for patients with benign disease awaiting elective surgery are mandatory to prevent further aggravation of the
overloaded healthcare systems.
1. Introduction
On March 11, 2020, the World Health Organization (WHO) declared
the coronavirus disease-19 (COVID-19) a public health emergency with
a pandemic spread [1]. As of June 20, 2020, more than 8,525,042
confirmed cases have been reported in 216 Countries across the world
[1]. Almost 20% of COVID-19 patients develop severe illness, requiring
hospitalization (15%) and intensive care support (5%) [2].
In many Countries, the healthcare systems are shifting the allocation
of medical resources according to the evolution of the COVID-19
burden. To maintain the ability of hospitals to treat a large influx of
potential COVID-19 patients, elective surgical activities addressing be-
nign diseases have been suspended or limited [3]. However, elective
surgery is not optional: indeed, being “presently non-urgent” does not
mean being “unnecessary” [4]. Moreover, benign diseases scheduled for
elective surgery may eventually lead to severe morbidity, which cannot
always be harmlessly postponed.
Cholelithiasis is one of the most common medical issues in devel-
oped Countries, affecting roughly 20% of the population, and being
symptomatic in one third of the cases [5]. Laparoscopic cholecys-
tectomy is a well-established treatment for gallstone disease (GD) [6].
Indeed, GD is the most common gastrointestinal disorder requiring
hospitalization in European Countries [6]. The annual risk of devel-
oping complications (acute pancreatitis, acute cholecystitis and cho-
langitis), which will cause frequent hospitalization, has been estimated
to be 1–3% [5,6].
We conducted an international multi-center survey to evaluate the
impact of the COVID-19 outbreak on the management of patients with
GD scheduled for cholecystectomy, with the aim of defining possible
strategies for their optimal management in the current pandemic sce-
nario.
2. Methods
This study was conducted using an open, voluntary, Web-based
qualitative survey designed in accordance with the “Consolidated
Criteria for Reporting Qualitative Research” (COREQ) [7] and the
“Checklist for Reporting Results of Internet E-Surveys” (CHERRIES) [8].
The survey was created by authors RA/TMM (MD, PhD) and distributed
through a structured network involving an electronic mailing list
through the academic account held by the University of Rome Tor
Vergata, Italy. An informed consent was obtained for the participation
in this study, and no incentives were offered to participants. The survey
involved only healthcare professionals, and did not include any patient
records or confidential data, therefore no ethical approval or patient
consent form were required. The survey was dispensed from March 30,
2020 to April 5, 2020 to senior surgeons (with over 5 years of experi-
ence) working in Hepato-Prancreato-Biliary units across Europe, Asia,
Oceania, and North and South America. Surgeons from Countries un-
dergoing different pandemic phases were purposely selected. At the
time of the study design, Belgium, Italy, France, the Netherlands, Spain,
Switzerland and UK were on an upward trajectory of the epidemic
curve, while Australia, Chile, India, Pakistan, Saudi Arabia and the US
were in the early phases of local transmission and Singapore had
achieved a flattening of the infection curve [1].
The 17-item online questionnaire (Table 1) was designed using
Google Forms (Mountain View, CA, USA) and sent via a secure email
link. The completion of the survey required approximately 10min. All
the relevant information about the questionnaire and the study was
provided to the participants prior to starting, and respondents were able
to withdraw from the analysis at any point. Written responses were
collected and analyzed using Microsoft Excel (Redmond, WA, USA) by
authors RA/TMM/AP. Participants were asked about the characteristics
of their surgical units, including the type of national/local health
system, the volume of GDs treated at the Center, the rate of GD
symptomatic patients versus those presenting complications, the
waiting list times, and the elective surgical approaches to cholecys-
tectomy. Participants were asked whether they had changed their usual
management of GD patients after the WHO declaration of a viral pan-
demic (March 11, 2020), and which strategy they had eventually
adopted based on the local context. GD was defined as the presence of
gallstones causing biliary colic, and complicated GD as gallstones
causing complications including cholecystitis, acute pancreatitis, bile
duct obstruction and cholangitis.
3. Results
Out of the 40 surgeons invited to participate in the survey, 36 re-
sponses from 14 Countries were obtained (response rate 90%), all of
which were included in the analysis. The majority (n=32, 88.8%) of
surgeons were based in Countries with a public health system, with 24
(66.7%) of them working in university hospitals, 7 (19.4%) in public
hospitals, 3 (8.3%) in private hospitals and 2 (5.6%) in military hos-
pitals.
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Table 1
Questionnaire used for the survey on the management of gallstone disease during the COVID-19 pandemic.
Question Multiple choice answer
1. In your Country, which kind of health system do you have? Public health system, with universal coverage
Mainly public health system, but without universal coverage
Mainly private health system
Only private health system





3. How many patients with gallstone disease are referred to your unit in one month? < 10
10–20
>20
4. How many patients with gallstone diseases are frequently symptomatic? > 25%
25–50%
>50%
5. How many patients with gallstone disease are currently on the waiting list for




6. How many patients with gallstone disease on your waiting list for cholecystectomy have had






7. How many patients with gallstone disease on your waiting list for cholecystectomy have














10. How many cholecystectomies are performed in ambulatory regimen (one day admission)





11. Since COVID-19 pandemic, how did your hospital change its organization? My hospital is exclusively dedicated to COVID-19 patients
My hospital has restricted areas dedicated to COVID-19 patients
My hospital doesn't treat COVID-19 patients
12. Since the COVID-19 pandemic, did you change the management of patients with gallstone
disease waiting for cholecystectomy?
No
Yes, we are not currently operating patients with gallstone disease
Yes, we currently operate only patients with complicated gallstone disease
Yes, the waiting list for cholecystectomy has been transferred to other hospitals
13. If you changed the management of patients with gallstone disease waiting for










Yes, only patients with respiratory symptoms or suspect of SARS-CoV-2 infection
Othera
15. Since the COVID-19 pandemic, what is the decrease in the percentage of cholecystectomy






16. Since the COVID-19 pandemic, did you change the surgical technique for cholecystectomy
from laparoscopy to open procedure?
No
Yes, I'm currently doing open cholecystectomy in all patients
Yes, I'm currently doing open cholecystectomy only in patients with known or
suspected SARS-CoV-2 infection
17. How would you face the management of patients with gallstone disease waiting for
cholecystectomy during the COVID-19 pandemic?
I suggest to postpone cholecystectomy for patients with gallstone disease until
the end of COVID-19 outbreak in our Country
I suggest to maintain the service of cholecystectomy only for patients with
complicated gallstone disease, ensuring dedicated pathway and operating
theatres
I suggest to maintain the service of cholecystectomy for all patients with
gallstone disease, ensuring dedicated pathway and operating theatres
I suggest to move all patients with gallstone disease waiting for cholecystectomy
in Hospital not treating COVID-19 patients
Othera
Abbreviations: COVID-19, coronavirus disease-19; ERCP, endoscopic retrograde cholangiopancreatography.
a = in this filed all participants had the opportunity to make comments.
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Twenty-three (63.9%) participants worked in high-volume units
(> 20 with referred GD patients/month), 8 (22.2%) in medium-volume
units (10–20 patients/month) and 5 (13.9%) in low-volume units (< 10
patients/month). Twenty-seven (75%) surgeons reported that the GD
patients listed for cholecystectomy in their Centers suffered from fre-
quent symptoms, and 10 (27.8%) stated that more than 25% of their
patients had experienced complications; less than 25% of these patients
had already undergone endoscopic retrograde cholangiopancreato-
graphy for acute pancreatitis. Before the COVID-19 pandemic, the
average number of cholecystectomies performed in one month was>
20 in 18 (50%) Centers, 10–20 in 12 (33.3%) Centers, and<10 in 6
(16.7%) Centers. In half of the units examined (n=19, 52.8%), the
average waiting time for patients scheduled for elective cholecys-
tectomy was>1 month, and only 14 (38.8%) Centers made a sig-
nificant use (> 50%) of the ambulatory regimen for cholecystectomy
(Table 2).
Since the declaration of the COVID-19 pandemic, 32 (88.9%) par-
ticipants stated that their hospital had dedicated areas restricted to
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-in-
fected patients. Two (5.6%) hospitals became exclusively dedicated to
COVID-19 patients, while 2 (5.6%) are not treating COVID-19 patients
as yet.
Notably, the majority (n=26, 72.2%) of surgeons reported an
alarming decrease in the cholecystectomy rate for GD since the start of
the pandemic, regardless of the Country: 19 (52.7%) participants af-
firmed that they were not currently performing any cholecystectomy, 7
(19.4%) reported a 50–75% decrease in their surgical activity, and 10
(27.8%) reduced their rate of cholecystectomy by 25–50%. Only one
(2.8%) participant stated that his/her GD surgical activity was not re-
duced (Table 3).
None of the participants reported that their unit currently operated
on patients with GD, unless complications had occurred. In Countries
with a higher SARS-CoV-2 spread at the time of the survey – such as
Italy and the UK [1] – participants stated that not even patients with
complicated GD were currently being considered for surgery. The large
majority of surgeons (n=32, 88.9%) said that they expected these
changes to last for at least 3 more months. When asked how they would
manage GD patients waiting for cholecystectomy during the COVID-19
outbreak, 21 (58.3%) participants said that they would maintain the
service only for patients with complicated GD, with dedicated pathways
and operating rooms, 10 (27.8%) declared that they would recommend
postponing all interventions until the end of the outbreak, and 5
(13.9%) reported that they would transfer GD patients to a COVID-19-
free hospital.
The survey showed that the proportion of patients scheduled for GD
surgery undergoing a screening for the SARS-CoV-2 infection varies
depending on the COVID-19 burden in each Country; patients are
currently being screened for infection in 15 (41.6%) Centers [all from
Countries with a high incidence of infection transmission (1)] before
surgery, in 10 (27.8%) only in the presence of suspected infection, and
in 5 (13.9%) routinely.
As for the cholecystectomy technique, the majority of surgeons
(n=29, 80.6%) have currently adopted a laparoscopic approach as
standard surgery, 5 (13.9%) participants use an open approach in pa-
tients with known or suspected SARS-CoV-2 infection, and 2 (5.6%)
perform an open cholecystectomy in all patients.
4. Discussion
Since the COVID-19 outbreak reached pandemic levels, re-
commendations for the fair allocation of resources should be based on
the following principles: maximizing the benefits of medical interven-
tions, protecting and preserving the healthcare workforce, paying at-
tention not to allocate resources only on a first-come/first-served basis,
being responsive to evidence, and applying the same principles to both
COVID-19 and non-COVID-19 patients [9].
International surgical societies recommend to avoid elective sur-
gical procedures, including cholecystectomy, in order to ration the use
of the medical resources (ICU beds, ventilators, and personal protective
equipment) and the healthcare professionals needed to face the COVID-
19 pandemic [3]. Conversely, emergency and oncological surgeries
should be continued [3].
Our survey depicts a wide adherence to this rule. Cholecystectomy
is, in fact, reserved only for patients with acute GD-related complica-
tions. Of these, 70% of cases are treated surgically, while 30% are
managed by medical treatment alone. Although these results could be
expected, surprisingly, in terms of cancellation of GD surgery schedules,
responses did not differ among participants from Countries at different
stages of COVID-19 spread. This results in a large number of patients
affected by uncomplicated but symptomatic gallstones – 50% of whom
suffering from frequent colic – and by the uncertainty about when de-
finitive surgery could be performed. This scenario may conceivably
increase the risk of developing gallstone-related complications, such as
acute cholecystitis, cholangitis and acute pancreatitis, which would
inevitably require hospitalization, and eventually urgent care [5,6].
Gallstone-related acute pancreatitis – which has an annual incidence
ranging from 15 to 40/100,000 across different Countries [10,11] –
could potentially be a life-threatening complication, requiring urgent
endoscopic or surgical intervention. Additionally, a more advanced
disease at the time of surgery may result in increasingly morbid op-
erations, which are associated with prolonged hospital stay and higher
costs [4]. Since the global healthcare community has never faced a
dramatic scenario such as the COVID-19 pandemic, it is difficult to
forecast the effects of untreated GD and the development of its related
complications during and after COVID-19. Recent US reports [12,13]
show that the visits to the Emergency Department declined up to 50%
during the early period of the COVID-19 pandemic, due to the patients’
fear of contracting the SARS-CoV-2 infection. This led to an increase in
the mortality and morbidity rates for life-treating diseases, such as
cardiovascular events [14]. However, so far there are no specific data
available on GD-related complications [12]. Based on pre-pandemic
data, assuming that the current crisis could last for 10 weeks [15], over
23,400 cholecystectomies in Italy and 18,200 in UK would be delayed,
since almost all GD surgeries in these Countries have been suspended
[16].
This huge number of untreated GDs suggests that, in the current
COVID-19 pandemic, the surgeons’ responsibility should not only be to
care for emergency or oncological cases, but also to prevent patients
with benign, uncomplicated diseases from developing complications,
further aggravating the pressure on the health systems.
The surgical management of GD patients should be carefully
planned, considering: 1) the expectation of SARS-CoV-2 spread in each
Country; 2) the organization of the hospitals and resources available
during the COVID-19 pandemic; 3) the clinical status of patients on the
surgical waiting list, who should be monitored through regular phone
consultations and telemedicine.
Since this survey shows that 90% of hospitals are treating COVID-19
patients, dedicated COVID-19-free pathways and precautions should be
preserved for all other cases [17]. Most surgeons agree on the need to
proceed with surgery only in GD patients with complications. For un-
complicated symptomatic patients, who are treatable by laparoscopic
cholecystectomy – which usually doesn't require a post-operative ICU
stay – a possible alternative might be the wider use of ambulatory
surgery. The current survey shows that only 39% of Centers routinely
perform cholecystectomy in a day case ambulatory setting. It is well-
known that an ambulatory regimen is both feasible and cost-effective
[18,19], therefore this strategy could be a good option in the current
pandemic to limit any further hospital overload. However, the high
turnover of patients and healthcare providers in ambulatory care ser-
vices, despite reducing hospitalization, could be a further potential
source of viral infection among the medical staff in the course of their
daily activity. In this regard, it might be safer to ask patients to self-
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quarantine for 14 days prior to surgery, as well as to obtain a PCR
negative test before the operation. This, combined with a wider use of
personal protective equipment (PPE) and COVID-19-free dedicated
surgical pathways, could improve the number of ambulatory admis-
sions.
Alternatively, according to the initial experience of China and Italy
[17], in hospitals lacking day case surgical services, patients with GD
awaiting elective cholecystectomy should be transferred to other
COVID-19-free hospitals.
Since the start of the COVID-19 pandemic, concerns have been
raised regarding the safety of smoke evacuation during laparoscopic
surgery, as the virus could potentially spread during laparoscopy [17].
The results of our survey do not show any dramatic change in the GD
surgical technique during the pandemic. In fact, only 5.6% of partici-
pants perform an open cholecystectomy in all patients, whereas 80.6%
use a standard laparoscopic approach. However, 13.9% of participants
would use an open approach in patients with known or suspected SARS-
CoV-2 infection. In this regard, The Royal College of Surgeons re-
commends to consider laparoscopy only in selected individual cases,
where the clinical benefit to the patient substantially exceeds the risk of
potential viral transmission to the surgeons and the theatre teams in
that particular situation [20]. However, open cholecystectomy might
lead to an increased risk of post-operative infection, and therefore a
prolonged hospitalization, whereas laparoscopic cholecystectomy can
be safely performed as a day case surgical procedure, thus reducing the
hospitalization time [5,6]. Recently, even in confirmed or suspected
COVID-19 cases, some authors suggest to use safe and reliable filtering
and evacuation systems for pneumoperitoneum gases, which could
decrease the chances of viral spreading, enabling the safe use of the
laparoscopic approach [21]. In our opinion, protecting the healthcare
teams with a safety-first approach is mandatory; thus, with the PPE and
adequate smoke evacuation systems (filters, careful deflating, traps)
[21], laparoscopic cholecystectomy for GD could be safely performed.
This would lead to a reduced hospitalization time, which is extremely
helpful for some categories of patients affected by GD (i.e. high BMI and
the elderly). In addition, it could potentially spare medical personnel
and resources. However, the circulation of information on the COVID-
19 transmission is continuously evolving, and it is likely that further
data will come out in the next future to provide evidence-based re-
commendations for the surgical practice.
The results of this survey are limited by the small number of par-
ticipants for each Country, the heterogeneity of the surgical Centers and
the rapidly changing scenario of the COVID-19 pandemic. Furthermore,
since the survey was conducted during the initial four weeks of the
pandemic, it lacks the data regarding the outcome of GD complications
and their treatment after the COVID-19 outbreak. To address this issue,
further studies are needed.
To the best of our knowledge, this is the first study to show the
potential impact of the COVID-19 pandemic on a benign disease re-
quiring elective surgery, such as symptomatic GD. In the ongoing
COVID-19 emergency, there is a substantial risk that many other benign
diseases – which may develop complications if left without surgical
treatment until the end of the pandemic – could have unexpected
consequences for the healthcare systems. Therefore, as for life-saving
procedures, it is of paramount importance to generate updated guide-
lines for the fair management of patients with benign disease in need of
elective surgery during the pandemic, or immediately thereafter.
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